Arcosa, Inc.
ACA · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.22 | -0.71 | 0.04 | -1.05 |
| FCF Yield | 6.64% | 1.43% | 1.39% | 3.21% |
| EV / EBITDA | 15.83 | 11.76 | 6.08 | 12.50 |
| Quality | ||||
| ROIC | 3.23% | 4.70% | 9.06% | 3.15% |
| Gross Margin | 20.05% | 19.23% | 18.33% | 17.48% |
| Cash Conversion Ratio | 5.36 | 1.64 | 0.71 | 2.39 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.64% | 4.26% | 5.03% | 5.45% |
| Free Cash Flow Growth | 443.13% | 58.40% | -55.41% | -54.22% |
| Safety | ||||
| Net Debt / EBITDA | 3.95 | 1.31 | 0.85 | 2.41 |
| Interest Coverage | 2.79 | 6.50 | 11.26 | 4.59 |
| Efficiency | ||||
| Inventory Turnover | 5.71 | 4.64 | 5.80 | 5.18 |
| Cash Conversion Cycle | 71.52 | 81.79 | 79.32 | 86.07 |